Synlett 2024; 35(04): 451-454
DOI: 10.1055/s-0041-1738454
cluster
11th Singapore International Chemistry Conference (SICC-11)

Regioselective Ring Opening of Oxetanes Enabled by Zirconocene and Photoredox Catalysis

Kazuhiro Aida
,
Eisuke Ota  ∗
,
Junichiro Yamaguchi  ∗
This work was supported by JSPS KAKENHI Grants Nos. JP21H05213 (Digi-TOS) (to J.Y.) and JP20K15290 (to E.O.), the Sumitomo Foundation (to E.O.), the Satomi Foundation (to E.O.), and Daiichi Kigenso Kagaku Kogyo (to E.O.). This work was also partly supported by JST ERATO Grant No. JPMJER1901 (to J.Y.).
› Further Information
    Permissions and Reprints All articles of this category


Abstract

Oxetanes are frequently utilized in organic synthesis, both as target products and as fairly reactive intermediates. Whereas ring cleavage of oxetanes through polar mechanisms has been extensively investigated, their radical-based counterparts remain underexplored. We used zirconocene and photoredox catalysis to open an oxetane ring in a radical manner. In our protocol, the reaction selectively delivers the more-substituted alcohols via putative less-stable radicals. This method not only affords the corresponding hydrogenated products, but also provides unique benzylidene acetal products.

Key words

zirconocene - photoredox catalysis - oxetanes - reverse regioselectivity - C–O bond homolysis - radicals

Supporting Information

    Supporting information for this article is available online at https://doi.org/10.1055/s-0041-1738454.
  • Supporting Information


Publication History

Received: 01 July 2023

Accepted after revision: 14 August 2023

Article published online:
27 October 2023

© 2023. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References and Notes

  • 1 Bull JA, Croft RA, Davis OA, Doran R, Morgan KF. Chem. Rev. 2016; 116: 12150
    CrossrefPubMed

      • For recent [2+2]-cycloaddition methods and MHAT examples, see:
    • 2a Flores DM, Schmidt VA. J. Am. Chem. Soc. 2019; 141: 8741
      CrossrefPubMed
    • 2b Rykaczewski KA, Schindler CS. Org. Lett. 2020; 22: 6516
      CrossrefPubMed
    • 2c Zheng J, Dong X, Yoon TP. Org. Lett. 2020; 22: 6520
      CrossrefPubMed
    • 2d Osato A, Fujihara T, Shigehisa H. ACS Catal. 2023; 13: 4101
      Crossref
  • 3 For another recent example of the construction of an oxetane ring, see: Qi D, Bai J, Zhang H, Li B, Song Z, Ma N, Guo L, Song L, Xia W. Green Chem. 2022; 24: 5046
    CrossrefPubMed

      • For recent C–H functionalizations, see:
    • 4a Ravelli D, Zoccolillo M, Mella M, Fagnoni M. Adv. Synth. Catal. 2014; 356: 2781
      Crossref
    • 4b Jin J, MacMillan DW. C. Angew. Chem. Int. Ed. 2015; 54: 1565
      CrossrefPubMed
  • 5 Eigenmann HK, Golden DM, Benson SW. J. Phys. Chem. 1973; 77: 1687
    CrossrefPubMed
  • 6 Ahmad S, Yousaf M, Mansha A, Rasool N, Zahoor AF, Hafeez F, Rizvi SM. A. Synth. Commun. 2016; 46: 1397
    Crossref
  • 7 For a recent enantioselective protocol, see: Strassfeld DA, Wickens ZK, Picazo E, Jacobsen EN. J. Am. Chem. Soc. 2020; 142: 9175
    CrossrefPubMed
  • 8 Gansäuer A, Ndene N, Lauterbach T, Justicia J, Winkler I, Mück-Lichtenfeld C, Grimme S. Tetrahedron 2008; 64: 11839
    CrossrefPubMed
  • 9 Takekoshi N, Miyashita K, Shoji N, Okamoto S. Adv. Synth. Catal. 2013; 355: 2151
    CrossrefPubMed
  • 10 Sugiyama Y, Heigozono S, Okamoto S. Org. Lett. 2014; 16: 6278
    CrossrefPubMed
  • 11 Potrząsaj A, Ociepa M, Chaładaj W, Gryko D. Org. Lett. 2022; 24: 2469
    CrossrefPubMed
  • 12 Aida K, Hirao M, Funabashi A, Sugimura N, Ota E, Yamaguchi J. Chem 2022; 8: 1762
    CrossrefPubMed
  • 13 Seto R, Yamada S, Matsumoto K, Endo T. Polym. Bull. (Heidelberg, Ger.) 2019; 76: 3355
    CrossrefPubMed
  • 14 Okita T, Aida K, Tanaka K, Ota E, Yamaguchi J. Precis. Chem. 2023; 1: 112
    CrossrefPubMed
  • 15 Funk P, Richrath RB, Bohle F, Grimme S, Gansäuer A. Angew. Chem. Int. Ed. 2021; 60: 5482
    CrossrefPubMed
  • 16 2-Hydroxybutyl Benzoate (2A); Typical Procedure 1,4-CHD (58.6 μL, 0.60 mmol, 3.0 equiv) and oxetane 1A (0.20 mmol, 1.0 equiv) were added to a solution of Ir(4-MeOppy)3 (4.5 mg, 6.0 μmol, 3.0 mol%), Cp2Zr(OTf)2·THF (5.9 mg, 10 μmol, 5.0 mol%), and TU1 (20.0 mg, 120 μmol, 60 mol%) in THF (2.0 mL), and the resulting mixture was irradiated with a 456 nm LED (Kessil) for 12 h. The mixture was then passed through a short silica gel pad with EtOAc as an eluent, and the filtrate was concentrated in vacuo. The residue was purified by preparative TLC (hexane/EtOAc = 2:1, then CHCl3/acetone = 9:1) to afford a colorless oil [Run 1; yield: 32.0 mg (84%), Run 2; yield: 24.4 mg (65%)]. 1H NMR (400 MHz, CDCl3): δ = 8.08–8.04 (m, 2 H), 7.60–7.55 (m, 1 H), 7.48–7.43 (m, 2 H), 4.41 (dd, J = 11.6, 3.2 Hz, 1 H), 4.25 (dd, J = 11.6, 6.4 Hz, 1 H), 3.96–3.89 (m, 1 H), 2.08 (d, J = 4.8 Hz, 1 H), 1.68–1.56 (m, 2 H), 1.04 (t, J = 7.2 Hz, 3 H). 13C NMR (101 MHz, CDCl3): δ = 166.7, 133.1, 129.9, 129.6, 128.4, 71.4, 68.8, 26.4, 9.8. The spectra were in accordance with those reported in the literature.17
  • 17 Iwasaki F, Maki T, Onomura O, Nakashima W, Matsumura Y. J. Org. Chem. 2000; 65: 996
    CrossrefPubMed